MENU
ADMA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
ADMA Biologics (ADMA) Earnings Date & Reports
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
ADMA is expected to report earnings to rise 17.22% to 19 cents per share on November 11
Q3'26
Est.
$0.19
Q2'26
Missed
by $0.01
Q1'26
Missed
by $0.01
Q4'25
Beat
by $0.01
Q3'25
Est.
$0.15
The last earnings report on August 05 showed earnings per share of 16 cents, missing the estimate of 17 cents. With 2.09M shares outstanding, the current market capitalization sits at 2.27B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
an operator of a specialty immune globulin, development and commercialization of human plasma and plasma-derived therapeutics
Industry Biotechnology
Industry
Biotechnology
Address
465 State Route 17
Phone
+1 201 478-5552
Employees
647
Web
https://www.admabiologics.com